Jul 21, 2020 / 01:30PM GMT
Operator
Good day, and welcome to the Sartorius and Sartorius Stedim Biotech Conference Call on the Half Year 2020 Results. Today's conference is being recorded.
At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO. Please go ahead.
Joachim Kreuzburg - Sartorius Aktiengesellschaft - Chairman of Executive Board & CEO
Thank you very much. Welcome to our conference call here today. Good morning, good afternoon, maybe even good evening in some cases. As always, we would like to walk you through the H1 results for the Sartorius Group and also present to you the full year's guidance for the Sartorius Group and after that, talk about the same, so the H1 results as well as the full year guidance for Sartorius Stedim Biotech. I'll do this together with our CFO, Rainer Lehmann. And before I hand over to him to walk you through the results for H1 in detail, I just would like to talk about maybe the key highlights for the first 6 months of this year.
We have achieved double-digit growth for sales revenue, order intake and
Q2 2020 Sartorius AG Earnings Call Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers